Aurobindo gets USFDA nod for Zaleplon capsules

This is the company's 70th approval from the USFDA.

Zaleplon capsules, the generic equivalent of King Pharmaceuticals' Sonata capsules, are indicated for the treatment of insomnia.

Aurobindo is in the first line of generics and got the FDA nod on the very first day, post the expiry of the relevant patent, and has already launched the product in the US market, the company stated in a press release on Tuesday.